Pfizer has claimed its first regulatory approval for a GLP-1 agonist in obesity, getting a green light in China for ecnoglutide, a once-weekly injectable drug licensed from Hangzhou-based Sciwind ...
Seeed Studio reBot Arm B601-DM is a fully open-source 6-axis robotic arm (plus a parallel gripper) designed to lower the ...
Ever since Ozempic started to get prescribed off-label for weight loss, obesity treatment—and our culture at large—has changed. At first, because of the demand, there were shortages. Now, you can get ...
Over 40% of people taking Xenical achieved a 5% decrease in their starting body weight. Saxenda users achieved a 5% decrease in their body weight in more than 63% of cases. Eating a balanced diet and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results